# 12. PHASE 5D — INTERPRETATION & VALIDATION REPORT

**Project Title:** Analysis of Seasonal Disease Patterns Using Government Health Data  
**Document Code:** PHASE-5D-DOC-12  
**Geography:** Maharashtra, India  
**Surveillance Source:** National Centre for Disease Control (NCDC) / Integrated Disease Surveillance Programme (IDSP)  
**Primary Baseline Cohort:** 2022–2025 Completed Calendar Years ($N = 539$ records; 21,955 reported cases; 266 reported deaths across 5 primary disease families)  
**Out-of-Sample Validation Cohort:** 2026 Epidemiological Weeks 01–32 ($N = 45$ records; 1,118 reported cases; 0 reported deaths)  
**Status:** Frozen Methodological Layer (Phase 5D)

---

## 1. Executive Summary & Purpose

Phase 5D constitutes the **interpretation and validation layer** of the research pipeline. Having completed the disease selection audit (Phase 5A), exploratory seasonal analysis (Phase 5B), and advanced mathematical modeling (Phase 5C), the objective of Phase 5D is to synthesize these technical outputs into rigorous, defensible, and academically sound research findings.

The central question governing this phase is:
> **“What does the complete analysis actually allow us to conclude about seasonal disease patterns in Maharashtra based on the NCDC/IDSP outbreak surveillance records?”**

To ensure absolute academic integrity, this report explicitly distinguishes:
1. **Findings strongly supported** by convergent multi-metric evidence and formal hypothesis testing;
2. **Findings supported descriptively** but subject to important surveillance caveats or geographic localization;
3. **Findings that are unstable, volatile, or outlier-driven**, where single high-case records distort summary aggregates; and
4. **Claims that strictly cannot be established** from secondary surveillance data (including population incidence, clinical etiology, and climate causation).

---

## 2. Cross-Phase Evidence Synthesis

The table below synthesizes the primary empirical metrics generated across Phase 5B (seasonal indices, monthly distributions) and Phase 5C (concentration metrics, peak windows, inter-annual stability, outlier sensitivity, district cohorts, and statistical testing) for the five primary disease families across the 2022–2025 baseline ($N = 539$ records).

| Empirical Dimension | Dengue ($N=204$) | Acute Diarrheal Disease ($N=153$) | Malaria ($N=70$) | Food Poisoning ($N=69$) | Chikungunya ($N=43$) |
| :--- | :--- | :--- | :--- | :--- | :--- |
| **Total Reported Cases** | 3,144 | 9,050 | 2,133 | 5,927 | 701 |
| **Total Reported Deaths**| 93 | 93 | 51 | 29 | 0 |
| **Case Fatality Ratio** | 2.96% | 1.03% | 2.39% | 0.49% | 0.00% |
| **Event CV & Gini** | $CV=0.736$, Gini=0.414 | $CV=0.524$, Gini=0.298 | $CV=0.753$, Gini=0.395 | $CV=0.564$, Gini=0.315 | $CV=0.515$, Gini=0.289 |
| **Case CV & Gini** | $CV=0.756$, Gini=0.423 | $CV=0.609$, Gini=0.344 | $CV=0.802$, Gini=0.450 | $CV=1.160$, Gini=0.534 | $CV=0.783$, Gini=0.421 |
| **Top-3 Month Share (CR3)**| Events: 50.5%, Cases: 49.9%| Events: 43.1%, Cases: 47.1%| Events: 51.4%, Cases: 54.8%| Events: 44.9%, Cases: 66.7%| Events: 39.5%, Cases: 52.5%|
| **Peak Window Type** | Discrete (Oct, Sep, Jun) | Contiguous (Jun–Aug) | Contiguous (May–Jul) | Discrete (May, Feb, Jan) | Discrete / Diffuse |
| **Peak Reported-Event Month** | October (19.6%) / Sep (17.6%)| October (16.3%) / Jul (14.4%)| June (21.4%) / Jul (20.0%) | May (15.9%) / Feb (15.9%) | May (14.0%) / Jun (14.0%) |
| **Kendall’s W Stability** | $W=0.405$ ($p=0.086$, Mod.)| $W=0.530$ ($p=0.016$, Sub.) | $W=0.319$ ($p=0.229$, Mod-Low)| $W=0.386$ ($p=0.108$, Mod.) | $W=0.150$ ($p=0.832$, Poor)|
| **Max Peak Displacement**| 4 months (Jun to Oct) | 6 months (Jun to Dec) | 2 months (May to Jul) | 4 months (Jan to May) | 6 months (May to Nov) |
| **Dominant Single Year** | 2023 (51.0% of events) | 2024 (46.4% of events) | 2024 (31.4% of events) | 2025 (42.0% of events) | 2024 (51.2% of events) |
| **Outlier Sensitivity** | **None:** Oct peak robust | **High:** Feb drops to #6 | **Moderate:** Dec drops to #3| **Extreme:** Feb drops to #3 | **High:** Oct peak shifts |
| **District Concentration**| Dispersed (31 dists, 8 qual)| Dispersed (33 dists, 3 qual)| Focal (Gadchiroli+Chandra=61%)| Dispersed (27 dists, 0 qual)| Focal (Pune = 25.6%) |
| **Statistical Tests Sig**| KW: Yes, MC: Yes, KW-W: No | KW: No, MC: Yes, KW-W: Yes | KW: Yes, MC: Yes, KW-W: No | KW: Yes, MC: Yes, KW-W: No | KW: No, MC: No, KW-W: No |
| **2026 W01–W32 Trajectory**| 6 events ($-73.6\%$, Trunc.)| 18 events ($-17.2\%$, Normal)| 1 event ($-91.7\%$, Deficit) | 19 events ($+49.0\%$, Shift) | 1 event ($-84.0\%$, Sparse) |
| **Evidence Tier** | **A. Strong Descriptive** | **B. Moderate Descriptive**| **B. Moderate Descriptive** | **C. Variable / Context** | **D. Insufficient Evidence**|

---

## 3. Evidence Strength Classification Framework

The five disease families are categorized into four transparent evidence tiers based on convergence between descriptive patterns, statistical tests under family-wise error control, inter-annual repeatability, spatial distribution, and resilience to outlier distortion.

```
+-----------------------------------------------------------------------------------+
|                           EVIDENCE STRENGTH HIERARCHY                             |
+-----------------------------------------------------------------------------------+
|  TIER A: STRONG DESCRIPTIVE EVIDENCE                                             |
|  - Dengue (Robust late-year concentration, Bonferroni-sig, multi-district aligned)|
+-----------------------------------------------------------------------------------+
|  TIER B: MODERATE DESCRIPTIVE EVIDENCE                                           |
|  - Acute Diarrheal Disease (High rank concordance, mid-year elevation; cases jump)|
|  - Malaria (Tightly recurrent May-Jul window; highly localized to E. Vidarbha)   |
+-----------------------------------------------------------------------------------+
|  TIER C: VARIABLE / CONTEXT-DEPENDENT EVIDENCE                                    |
|  - Food Poisoning (Non-uniform timing driven by discrete high-case outbreak logs) |
+-----------------------------------------------------------------------------------+
|  TIER D: INSUFFICIENT EVIDENCE                                                    |
|  - Chikungunya (Zero tests significant, severe sparsity, erratic annual profiles) |
+-----------------------------------------------------------------------------------+
```

### Detailed Classification Justifications:
1. **Dengue (Tier A — Strong Descriptive Evidence):**
   - *Supporting Evidence:* High concentration ($CV = 0.736$, $CR3 = 50.5\%$, Gini $= 0.414$); 82.8% of events concentrated in the June–October calendar window; Bonferroni-significant Kruskal-Wallis ($p = 0.00022$) and Monte Carlo permutation ($p = 0.0001$); 8 qualifying districts aligned in late-year reporting; complete resilience to outlier exclusion (October peak reported-event and reported-case month remains #1).
   - *Methodological Caveat:* The 2023 high-volume year accounts for 51.0% of baseline events, and inter-annual peak reported-event timing oscillates across a 4-month span (June to October).
2. **Acute Diarrheal Disease (Tier B — Moderate Descriptive Evidence):**
   - *Supporting Evidence:* Contiguous 3-month elevation window in June–August (43.1% of events); highest inter-annual rank concordance of any disease ($W = 0.530, p = 0.016$, exploratory FDR-significant); permutation test significant ($p = 0.0001$).
   - *Downgrade Reason:* Kruskal-Wallis test fails to reach significance ($p = 0.132$) due to high within-month inter-annual variance; reported case distribution is severely distorted by a single 1,000-case institutional outbreak in February 2024.
3. **Malaria (Tier B — Moderate Descriptive Evidence):**
   - *Supporting Evidence:* Highest event concentration ($CV = 0.753$, $CR3 = 51.4\%$); contiguous May–July window; tightest timing recurrence across all four years (maximum peak displacement of only 2 months); permutation test significant ($p = 0.0001$); Kruskal-Wallis significant under FDR ($p = 0.00546$).
   - *Downgrade Reason:* Severe geographic concentration: 61.4% of all baseline events originate from just two contiguous districts (Gadchiroli and Chandrapur). The pattern represents an Eastern Vidarbha regional surveillance phenomenon rather than a uniform statewide reporting profile.
4. **Food Poisoning (Tier C — Variable / Context-Dependent Evidence):**
   - *Supporting Evidence:* Statistical rejection of uniformity via Kruskal-Wallis ($p = 0.00568$) and permutation ($p = 0.0236$); complete absence of events in November across four years.
   - *Downgrade Reason:* Discontinuous bimodal distribution; Kendall’s $W$ non-significant ($p = 0.108$); February case volume is strongly influenced by three high-case outbreak records (1,615 cases); excluding them shifts the peak reported-case month to April. Events represent discrete point-source/mass-exposure records rather than calendar-month cycles.
5. **Chikungunya (Tier D — Insufficient Evidence):**
   - *Supporting Evidence:* None.
   - *Downgrade Reason:* Complete lack of statistical significance across all tests (Kruskal-Wallis $p = 0.355$, Permutation $p = 0.416$, Kendall’s $W = 0.150, p = 0.832$); severe event sparsity (only 43 events across four years, with 7 events in three of the four years); 25.6% of events concentrated in a single district (Pune); peak timing shifts across 6 months. The available 2022–2025 surveillance records do not establish a stable recurring calendar-month concentration for Chikungunya.

---

## 4. Disease-by-Disease Detailed Interpretation

### 4.1. Dengue
1. **Visible Pattern:** A pronounced later-year reporting concentration in the June–October calendar window. Baseline event reporting accelerates in June (13.2%), plateaus in July (12.8%) and August (9.8%), and peaks in September (17.6%) and October (19.6%).
2. **Concentration:** High. The top-3 months account for 50.5% of events and 49.9% of cases. The June–October window encompasses 82.8% of all reported baseline events.
3. **Multi-Year Recurrence:** Elevated reporting during June–October occurs in all four years. In 3 of 4 years, peak reported-event activity falls specifically in September or October.
4. **Peak Timing Displacement:** Maximum displacement is 4 months (peaking in September in 2022, October in 2023, June/July in 2024, and August in 2025). The 2024 season exhibited an unusually early summer surge.
5. **Event vs. Case Relationship:** Highly balanced. Event CR3 (50.5%) and Case CR3 (49.9%) are virtually identical. The mean cases per outbreak (15.4) remains stable across months (ranging from 10.0 in December to 23.1 in August).
6. **District Concentrations:** Widespread reporting across 31 districts. Eight districts met the academic qualification threshold ($N \ge 10$): Thane (19), Beed (15), Raigad (13), Kolhapur (13), Nanded (13), Aurangabad (10), Akola (10), and Pune (10). All qualifying cohorts showed consistent alignment with late-year reporting.
7. **Statistical Findings:** Kruskal-Wallis non-parametric test ($H = 35.325, p = 0.00022$) and Monte Carlo permutation ($Chi^2 = 110.353, p = 0.0001$) both reject uniformity under strict Bonferroni correction ($\alpha = 0.00333$). Kendall’s $W$ is moderate ($0.405, p = 0.086$).
8. **What Statistics Do NOT Establish:** Does not establish that weather directly caused the outbreak timing; does not measure entomological vector density; does not predict the timing of future dengue reporting.
9. **Principal Limitations:** Calendar year 2023 dominates the baseline volume (104/204 events, 51.0%), heavily weighting aggregate curves toward October; 2023 archive lacks published reports for Weeks 15, 51, and 52.

### 4.2. Acute Diarrheal Disease (ADD)
1. **Visible Pattern:** A sustained mid-year elevation spanning June through August (43.1% of events), accompanied by a secondary elevation in October (16.3% of events).
2. **Concentration:** Moderate. Event $CV = 0.524$, $CR3 = 43.1\%$, Gini $= 0.298$; reported outbreak events occurred across multiple calendar months, with higher event frequency during the identified mid-year window.
3. **Multi-Year Recurrence:** Substantial. Elevated June–August reporting is present in 3 of 4 baseline years. Inter-annual rank concordance is the highest of any disease family ($W = 0.530, p = 0.016$, exploratory FDR-significant).
4. **Peak Timing Displacement:** Dispersed across a 6-month span: peaking in December in 2022 (linked to an anomalous late-year mortality cluster), June/August in 2023, July in 2024, and October in 2025.
5. **Event vs. Case Relationship:** Severe divergence. In February, 9 events generated 1,582 cases (175.8 cases/event vs 59.2 overall), creating an artificial #1 peak reported-case month for the year driven by a single institutional outbreak.
6. **District Concentrations:** Broad reporting across 33 districts. Three districts qualified with $N \ge 10$: Nagpur (12 events, peaking in March), Amravati (11 events, peaking in July), and Kolhapur (10 events, peaking in December 2022). Mortality was heavily concentrated in Week 49 of 2022 (78 deaths out of 93 across the baseline).
7. **Statistical Findings:** Monte Carlo permutation rejects uniformity under Bonferroni correction ($p = 0.0001$). However, the Kruskal-Wallis test is non-significant ($H = 16.251, p = 0.132$), reflecting substantial year-to-year variance within monthly bins.
8. **What Statistics Do NOT Establish:** Does not prove water supply contamination was confined to mid-year; does not evaluate microbial etiology; does not measure population incidence.
9. **Principal Limitations:** Extreme sensitivity of case volume to single institutional clusters; high variance across years weakens parametric-style inference.

### 4.3. Malaria
1. **Visible Pattern:** A sharp concentration in the May–July calendar window. Event notifications rise in May (10.0%), peak in June (21.4%), remain elevated in July (20.0%), and decline steadily through later months.
2. **Concentration:** High. Event $CV = 0.753$, Top-3 Month $CR3 = 51.4\%$, Event Gini $= 0.395$. Over half of all baseline events fall in May–July.
3. **Multi-Year Recurrence:** Exceptionally high timing recurrence. The May–July window contains peak or near-peak activity in all four baseline years.
4. **Peak Timing Displacement:** Constrained to a 2-month window: May in 2022, May/Aug/Sep/Dec tied in 2023, July in 2024, and June in 2025.
5. **Event vs. Case Relationship:** December exhibits artificial case inflation: 6 events generated 448 cases (21.0% of cases), driven by a single 385-case cluster in Week 01 / late December. Peak reported-event month is firmly in June (21.4%).
6. **District Concentrations:** Strong geographic concentration. Two contiguous Eastern Vidarbha districts account for 61.4% of all baseline reported Malaria outbreaks in Maharashtra: Gadchiroli (27 events, 38.6%) and Chandrapur (16 events, 22.9%). Both districts peak in June/July.
7. **Statistical Findings:** Permutation test is Bonferroni-significant ($p = 0.0001$); Kruskal-Wallis is FDR-significant ($H = 26.503, p = 0.00546$). Kendall’s $W$ is non-significant ($0.319, p = 0.229$) due to small annual counts.
8. **What Statistics Do NOT Establish:** Does not establish a statewide disease pattern; does not prove vector entomological dynamics; does not reflect low-level endemic reporting in non-reporting districts.
9. **Principal Limitations:** The statewide aggregate profile is essentially a reflection of surveillance reporting in two Eastern Vidarbha districts.

### 4.4. Food Poisoning
1. **Visible Pattern:** A bimodal temporal distribution, clustering in late winter (January–February: 26.1% of events) and late spring (April–May: 29.0% of events), with zero events in November.
2. **Concentration:** Moderate Event Concentration ($CV = 0.564$, $CR3 = 44.9\%$), but Extreme Case Concentration ($CV = 1.160$, $CR3 = 66.7\%$, Gini $= 0.534$).
3. **Multi-Year Recurrence:** Point-source recurrence. Peak event activity alternates between winter (2024, 2025) and spring (2022, 2023), reflecting the occurrence of discrete point-source/mass-exposure records.
4. **Peak Timing Displacement:** Shifts across 4 months between January and May.
5. **Event vs. Case Relationship:** Extreme divergence. February accounts for 15.9% of events but 36.5% of cases (mean 196.5 cases/event), driven by three high-case outbreak records.
6. **District Concentrations:** Widely dispersed across 27 districts. Zero districts met the academic threshold of $N \ge 10$ events, confirming that events represent isolated localized incidents.
7. **Statistical Findings:** Kruskal-Wallis ($H = 26.389, p = 0.00568$) and permutation ($Chi^2 = 21.957, p = 0.0236$) are both FDR-significant. Kendall’s $W$ is non-significant ($0.386, p = 0.108$).
8. **What Statistics Do NOT Establish:** Does not establish a biological seasonal cycle; does not prove weather causation; does not predict future contamination risks.
9. **Principal Limitations:** Case counts are heavily influenced by a few high-case records rather than continuous calendar-month cycles.

### 4.5. Chikungunya
1. **Visible Pattern:** A diffuse, erratic distribution across calendar months without a discernible seasonal cycle.
2. **Concentration:** Low / Diffuse. Event $CV = 0.515$, $CR3 = 39.5\%$, Gini $= 0.289$.
3. **Multi-Year Recurrence:** None. Kendall’s $W$ is negligible ($0.150, p = 0.832$), and mean pairwise Spearman rank correlation is negative ($-0.082$).
4. **Peak Timing Displacement:** Erratic 6-month displacement (May, July, June/November, August).
5. **Event vs. Case Relationship:** Distorted by small numbers: a single 145-case outbreak in Kolhapur during October 2023 accounts for 20.7% of all baseline cases.
6. **District Concentrations:** Pune district accounts for 25.6% of all baseline events (11/43) and is the only district with $N \ge 10$.
7. **Statistical Findings:** All three statistical tests are non-significant ($p > 0.35$).
8. **What Statistics Do NOT Establish:** Does not confirm or refute whether chikungunya outbreak reporting is seasonal; does not provide an actionable timing window for surveillance operations.
9. **Principal Limitations:** Extreme event sparsity (averaging 7 to 22 events/year) prevents meaningful statistical inference.

---

## 5. Cross-Disease Neutral Comparison

To avoid arbitrary ordinal rankings, the table below compares the five primary disease families across six objective surveillance dimensions:

```
+---------------------------------------------------------------------------------------------------------------+
|                                      CROSS-DISEASE COMPARATIVE SUMMARY                                        |
+----------------------+--------------------+--------------------+-----------------------+----------------------+
| Disease Family       | Temporal Focus     | Geographic Breadth | Event-Case Alignment  | Outlier Resilience   |
+----------------------+--------------------+--------------------+-----------------------+----------------------+
| Dengue               | Late-Year (Jun-Oct)| Statewide (31 dst) | High (Balanced)       | Highly Resilient     |
| Acute Diarrheal Dis. | Mid-Year (Jun-Aug) | Statewide (33 dst) | Divergent (Feb Mega)  | Case-Sensitive       |
| Malaria              | Early-Year(May-Jul)| Regional (Vidarbha)| Divergent (Dec Cluster| Case-Sensitive       |
| Food Poisoning       | Bimodal (Late W/Sp)| Dispersed (27 dst) | Extreme Divergence    | Extremely Sensitive  |
| Chikungunya          | Diffuse / Erratic  | Focal (Pune 26%)   | Divergent (Oct Cluster| Small-Sample Sensitive|
+----------------------+--------------------+--------------------+-----------------------+----------------------+
```

### Neutral Comparative Insights:
- **Temporal Window Differences:** Malaria outbreak reporting concentrates earlier in the calendar year (May–July) than Dengue (June–October), while ADD exhibits a broad mid-year swell (June–August).
- **Spatial Distribution Contrast:** Dengue and ADD represent broad statewide surveillance reporting patterns, whereas Malaria is heavily concentrated in Eastern Vidarbha (61.4%), and Chikungunya is disproportionately captured in Pune (25.6%).
- **Outlier Vulnerability Contrast:** Dengue exhibits the highest distributional resilience to individual mega-events, whereas Food Poisoning case totals are heavily influenced by a small number of high-case records.

---

## 6. Stability vs. Volatility Analysis

This analysis explicitly dissects the dataset into three distinct behavioral categories to prevent mistaking temporary spikes for recurring cycles:

1. **Recurring Patterns (Multi-Year Timing Consistency):**
   - Dengue’s late-year elevation (June–October) recurs across all four baseline years.
   - ADD’s mid-year elevation (June–August) recurs in 3 of 4 baseline years with substantial rank concordance ($W = 0.530$).
   - Malaria’s May–July calendar window recurs in all four baseline years within a 2-month window.
2. **Year-Specific Patterns (Inter-Annual Volatility):**
   - Dengue experienced a high-volume reporting year in 2023 (104 events, 51.0% of baseline), which shifted the aggregate peak to October.
   - ADD experienced an anomalous late-year mortality cluster in December 2022 (78 deaths) and a higher event count in 2024 (71 events, 46.4% of baseline).
   - Food Poisoning event frequency expanded in 2025 (29 events, 42.0% of baseline).
3. **Outlier-Driven Patterns (Isolated Exposure Events):**
   - Food Poisoning’s February case peak is an artifact of 3 high-case records (1,615 cases).
   - ADD’s February case peak is an artifact of 1 institutional record in Nanded (1,000 cases).
   - Malaria’s December case peak is an artifact of 1 cluster in Gadchiroli (385 cases).

---

## 7. Out-of-Sample 2026 Validation (W01–W32)

Treating 2026 strictly as a partial-year out-of-sample comparison ($N = 45$ records across W01–W32) establishes four vital validation findings:

1. **ADD Surveillance Alignment:** ADD recorded 18 events in W01–W32, closely tracking its historical 4-year mean of 21.8 events ($-17.2\%$), confirming steady mid-year surveillance reporting.
2. **Reporting Label Observations:** 18 ADD records were reported in 2026 W01–W32, and all used the British spelling *"Diarrhoeal"*. Food Poisoning recorded 19 reported events in 2026 W01–W32, while all 19 records used the "Suspected Food Poisoning" label. The simultaneous occurrence of these observations does not establish a causal or administrative relationship.
3. **Food Poisoning Recorded Volume:** Food Poisoning recorded 19 events ($+49.0\%$ above the historical mean of 12.8 events).
4. **Dengue Truncation Caveat:** Dengue recorded 6 events ($-73.6\%$ below historical mean). However, because 55.4% of Dengue events historically occur in Weeks 33–52, this early deficit cannot be used to infer an overall mild year or project future trends.
5. **Malaria Surveillance Deficit:** Malaria recorded only 1 event in Gadchiroli ($-91.7\%$ below historical mean), representing a marked reduction in reported events in surveillance records that warrants investigation into local field reporting practices.

---

## 8. District-Level Validation

Screening the 36 districts against an academic sample threshold ($N \ge 10$ baseline events) identified 13 qualifying district cohorts:
- **Dengue (8 cohorts):** Thane (19), Beed (15), Raigad (13), Kolhapur (13), Nanded (13), Aurangabad (10), Akola (10), and Pune (10). All qualifying cohorts demonstrated alignment with late-year reporting, validating Dengue as a statewide surveillance phenomenon.
- **ADD (3 cohorts):** Nagpur (12), Amravati (11), and Kolhapur (10). Vidarbha cohorts aligned with mid-year reporting, while Kolhapur reflected the December 2022 mortality cluster.
- **Malaria (2 cohorts):** Gadchiroli (27) and Chandrapur (16). Together they account for 61.4% of all baseline reported events (43/70 events), proving that statewide Malaria curves reflect Eastern Vidarbha dynamics.
- **Chikungunya (1 cohort):** Pune (11 events, 25.6% of baseline), reflecting specialized tertiary surveillance capacity.

*Critical Epistemological Distinction:* These distributions reflect **where outbreak events were reported into the surveillance system**, not necessarily where overall community infection was highest.

---

## 9. Methodological & Surveillance Limitations

Ten primary limitations define the epistemological boundaries of this research:
1. **Surveillance Capture vs. Incidence:** Outbreak reports capture clustered public health emergencies; they do not measure population incidence, prevalence, or individual disease risk.
2. **Geographic Reporting Variation:** Notification diligence varies across District Surveillance Units and presence of medical colleges.
3. **Published Archive Gaps:** 2023 archive lacks published reports for Weeks 15, 51, and 52.
4. **2026 Partial Truncation:** 2026 covers only W01–W32; W33–W52 unobserved.
5. **Nomenclature Standardization:** Conservative family mapping required standardizing 49 raw labels into 30 families while isolating combination labels.
6. **Temporal Auto-Correlation:** Non-parametric tests evaluate calendar non-randomness, not parametric independence.
7. **Simulation Resolution Limits:** 10,000 Monte Carlo draws impose an empirical resolution floor of $p = 0.0001$.
8. **Exploratory Concordance:** Kendall’s $W$ evaluates $m = 4$ annual profiles, rendering p-values exploratory.
9. **Sample Thresholds:** District inference restricted to cohorts with $N \ge 10$.
10. **Case Aggregate Distortion:** For this analysis, reported event counts provide a less case-volume-sensitive measure of temporal reporting frequency than raw case counts, particularly where individual mass-exposure records dominate case totals.

---

## 10. Research Alignment & Unsupported Claims

- **Research Alignment:** The analysis directly satisfies the central research question and all eight formal objectives from the project framework (`08_RESEARCH_ALIGNMENT.md`).
- **Unsupported Claims:** The dataset strictly **cannot** establish population incidence, prevalence, climate causation, biological vector mechanisms, community transmission pathways, individual infection risk, future 2026 forecasts, or ordinal disease rankings (`10_UNSUPPORTED_CLAIMS.md`).
- **Viva Voce Defense:** Sixteen demanding examiner challenge questions covering all methodology components are prepared with defensible answers (`11_VIVA_EXAMINER_QUESTIONS.md`).

---

## 11. Final Methodological Conclusion

Phase 5D successfully converts the technical outputs of Phases 5A, 5B, and 5C into defensible, academically grounded findings. By relying on **notified outbreak event counts**, evaluating **distributional concentration rather than raw totals**, performing **systematic sensitivity testing**, and strictly **qualifying surveillance boundaries**, the analysis provides an authoritative, fully auditable foundation for public health outbreak preparedness in Maharashtra.
